T-cell lymphoblastic lymphoma
GPTKB entity
Statements (82)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
T-cells
lymphatic system |
| gptkbp:associated_with |
genetic mutations
|
| gptkbp:can_lead_to |
gptkb:healthcare_organization
infection risk long-term complications |
| gptkbp:caused_by |
viral infections
splenomegaly bone marrow infiltration |
| gptkbp:has_achievements |
secondary malignancies
tumor lysis syndrome metabolic disturbances |
| gptkbp:hosts |
targeted therapy
|
| https://www.w3.org/2000/01/rdf-schema#label |
T-cell lymphoblastic lymphoma
|
| gptkbp:is_associated_with |
autoimmune diseases
chronic inflammation immunodeficiency psychological impact elevated LDH levels poor prognosis in advanced stages CNS involvement |
| gptkbp:is_characterized_by |
rapid growth
high mitotic activity abnormal cell proliferation cellular atypia immature T-cells lymphoid tissue infiltration |
| gptkbp:is_effective_against |
gptkb:theorem
|
| gptkbp:is_influenced_by |
environmental factors
lifestyle factors genetic predisposition |
| gptkbp:is_monitored_by |
regular follow-ups
response to treatment |
| gptkbp:is_often_depicted_as |
males
|
| gptkbp:is_often_used_in |
gptkb:Person
young adults |
| gptkbp:is_part_of |
hematologic malignancies
lymphoproliferative disorders oncology studies |
| gptkbp:is_recognized_by |
specific symptoms
specific markers |
| gptkbp:is_related_to |
gptkb:healthcare_organization
|
| gptkbp:is_studied_in |
gptkb:hospital
|
| gptkbp:is_used_for |
skin lesions
mediastinal mass |
| gptkbp:managed_by |
symptom control
|
| gptkbp:origin |
thymus
|
| gptkbp:recognizes |
flow cytometry
|
| gptkbp:requires |
palliative care
rehabilitation services nutritional support genetic counseling psychosocial support multidisciplinary approach end-of-life care stem cell transplant intensive treatment |
| gptkbp:scientific_classification |
gptkb:non-Hodgkin_lymphoma
gptkb:high-grade_lymphoma primary or secondary |
| gptkbp:social_responsibility |
imaging studies
clinical evaluation biopsy varies by stage molecular testing |
| gptkbp:symptoms |
weight loss
fever night sweats lymphadenopathy |
| gptkbp:treatment |
gptkb:vaccine
gptkb:municipality clinical trials supportive care radiation therapy chemotherapy oncologists specialized centers antineoplastic agents |
| gptkbp:type |
gptkb:healthcare_organization
|
| gptkbp:bfsParent |
gptkb:ALK
|
| gptkbp:bfsLayer |
5
|